Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,016) with videos related to
Page
of 102
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 16, 2010
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research
Elizabeth Shane, David Burr, Peter R Ebeling, et al.
Journal of Medicinal Chemistry
|
September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers
Shota Kikuchi, Jason C Green, Don C Rogness, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Journal of Medicinal Chemistry
|
July 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
Stephen T Wrobleski, Ryan Moslin, Shuqun Lin, et al.
Nature Genetics
|
July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression
Johannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression
Johannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2017
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong, David S Weinstein, Zhonghui Lu, et al.
Page
of 102
Search research articles
Search
Showing results (1001-1010 of 1,016) with videos related to
Sort By:
Page
of 102
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 16, 2010
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research
Elizabeth Shane, David Burr, Peter R Ebeling, et al.
Journal of Medicinal Chemistry
|
September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers
Shota Kikuchi, Jason C Green, Don C Rogness, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Journal of Medicinal Chemistry
|
July 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
Stephen T Wrobleski, Ryan Moslin, Shuqun Lin, et al.
Nature Genetics
|
July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
Shuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression
Johannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression
Johannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2017
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong, David S Weinstein, Zhonghui Lu, et al.
Page
of 102